Over the last 150 years there has been an enormous gain in our understanding of the role of the microbial flora in food preservation, spoilage and the threats to our health. At the same time, improvements in process technology have been accompanied by massive changes in the scale of many milk processing operations, and the manufacture a wide range of dairy and other related products.
The Society has embarked on a project with Wiley-Blackwell to produce a technical series of dairy-related books to provide an invaluable source of information for practicing dairy scientists and technologists, covering the range from small enterprises to modern large-scale operation. This, the fourteenth volume in the series, on Microbial Toxins in Dairy Products, provides a timely and comprehensive update of the potential and possible routes for contamination, techniques for detection and how this knowledge can be used to reduce the risks to the consumer.
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Food-borne diseases, including dairy products, have been recognised as major threats to human health and can affect the national economies of both industrialised and developing countries worldwide. It can be argued that some of the causes associated with dairy food-borne diseases are the use of raw milk in the manufacture of dairy products, faulty processing conditions during the heat treatment of milk, contamination of products after post-processing, failure in due-diligence (i.e. adding processed food to dairy products, for example, the case of botulism in hazel nut yoghurt in the United Kingdom), in-adequate clean water supply, and so on. Primarily, dairy food-borne diseases affecting human health are associated with certain strains of bacteria (e.g. belonging to the genera of Clostridium, Bacillus, Escherichia, Staphylococcus and Listeria) that are capable of producing toxins, plus moulds that are similarly capable of producing mycotoxins, such as aflatoxins, sterigmatocytin and ochratoxin. In addition, biogenic amines can accumulate in dairy products through microbial activity (e.g. starter cultures in cheeses), where the ingestion of high concentrations can be dangerous to human health. Incidences of human illnesses associated with dairy products are relatively low compared with foodborne illnesses in general. The purpose of this book, which is written by a team of well-known international scientists, is to review the latest scientific knowledge/developments in these fields, such as surveying the incidences of human illnesses caused by the consumption of dairy products, updating the analytical techniques required to examine bacterial and mould toxins, and the potential for contamination of milk as it passes along the food chain (i.e. from 'farm-to-fork'). This is complemented by a review of current approaches used to model microbial growth and toxin production plus the associated risks, and the regulatory measures available in different countries for control of microbial toxins in dairy products. It is anticipated that this up-dated information will help to further minimise the incidences of dairy food-borne illnesses in humans.
I would like to acknowledge the time and effort that the expert contributors have given to make this edition possible. Although some overlap of scientific data have occurred in some chapters, I have felt justified in allowing this overlap because it has resulted in making the chapter(s) easier to read and understand. 
Introduction
Microbial toxins can be and often are troublesome to human health and well-being. History records numerous occurrences of death and suffering caused by disease organ isms, such as Yersinia pestis, of bubonic plague or Black Death fame, Corynebacterium diptheriae and Vibrio cholerae, the causative organism of diptheria and cholera respec tively, as their names suggest, Bordetella pertussis, which causes whooping cough, and Salmonella enterica subsp. enterica serotype Typhi, which causes typhoid. Although these bacterial pathogens exhibit very different aetiologies in terms of vectors and modes of infection, they are all similar in that they cause disease by means of toxins. The word 'toxin' is derived from the ancient Greek language, and refers to poison pro duced by living cells or organisms; although today it has a wider application, and can apply to synthetic compounds. Modern medicine, linked with improvements in sanitation and other public health measures, has reduced the incidence of many bacterially mediated diseases, particularly in technologically developed societies. Since the nineteenth century, our scientific understanding of the mechanisms by which these organisms proliferated and caused disease has increased greatly. Our ability to treat the diseases by means of vaccines and antibiotics has meant that for many people today, the spectre of the once common ill nesses and death that the organisms represented no longer hovers close to society. This is not to say, however, that illness and disease caused by micro-organisms and their toxins are no longer problematic. While diseases, such as diptheria, cholera and typhoid are relatively uncommon today, modern consumers all too often encounter the actions and consequences of microbial toxins, particularly bacterial toxins. When they con sume food products that have been contaminated and/or mismanaged, often during production, a consequence can be affliction with food-borne disease, commonly referred to as food poisoning.
All food businesses engaged in the production, processing, manufacture, distribution and sale of food products to consumers have to be concerned about food safety and the problem of food-borne disease. The dairy industry is no exception. Although dairy products are amongst the safest of food products, because of the exceptionally high standards of general management, and specifically hygiene and food safety management, employed throughout the dairy chain, from farm to supermarket, the potential exists for dairy products to be involved in the occurrence of food-borne disease. The food safety management strategies of dairy farmers, milk processors and milk products manufactur ers are designed and implemented precisely to safeguard consumers. An important part of the strategies concerns understanding the nature of the food-borne disease organisms that may be associated with dairy products, and how to minimise the risk of their occur rence in products.
The purpose of this chapter is to review the issue of toxins associated with dairy products and specifically those of microbial origin, thereby setting the scene for the rest of the book.
Microbial toxins: modes of action
Toxigenesis is the ability to produce toxins and the sources of microbial toxins that may be associated with dairy products are two-fold: (a) those produced by bacteria, and (b) those produced by fungi (or moulds). Bacterial toxigenesis is very significantly of greater concern to the dairy industry and consumers of milk products than are toxins produced by fungi, although the latter are not unimportant.
Bacterial toxins are commonly designated as endotoxins and exotoxins. Most Gramnegative bacteria and all Enterobacteriacea produce endotoxins (Lüderitz et al., 1966) . These toxins are commonly components of bacterial cell walls in the form of lipopolysac charides, and are compounds composed of three units: (a) the lipid A component, which is hydrophobic in nature, (b) the core oligosaccharide (consisting of an inner and outer core), the structure of which varies diversely according to bacterial species and subspecies, and (c) the O polysaccharide, or O antigen as it is also known. The somatic antigen is located in the cell wall of both Gram-positive and Gram-negative bacteria. However, the somatic O antigen is exhibited by many organisms, including salmonellas and the well-known Escherichia coli O157:H7, of which the letter O is at times erroneously reproduced as the numeral zero. Like the core oligosaccharide, the structure of the O antigen also varies widely according to bacterial species and subspecies.
As biologically active, heat stable endotoxins, lipopolysaccharides are commonly associated with the infections and variety of symptoms caused by Gram-negative bacte ria. The lipopolysaccharide structures are released from the cell walls of pathogenic bacteria as they break down, or autolyse, following the normal path of death and decay, or experience externally mediated lysis such as when attacked by the immune system of the host organism. Lipid A is the toxic component of the lipopolysaccharide, considered by some to be the most potent element, although Bishop (2005) noted that other inflam matory compounds may be derived from bacteria, such as the diacylgly cerylcysteine component of bacterial lipoproteins and nucleic acids amongst others. Because of its hydrophobic nature, lipid A attaches to and becomes embedded in the cell wall of the host cell, interfering with the normal transport and cell regulation processes undertaken by the cell wall. This has the consequence of causing inflammatory and other responses, including in some instances toxic shock, to the host organism.
Exotoxins, in contrast to endotoxins, are toxic compounds released by bacterial cells. They are commonly enzymes, although some are polypeptides. In some few cases, lipopolysaccharides may be secreted as exotoxins. Exotoxins are proteinaceous com pounds secreted by bacterial cells locally to the point of action or at some distance from the tissue sites that they affect. For example, amongst the range of toxins produced by the Gram-positive organism Staphylococcus aureus, one is a protein enterotoxin that may be secreted onto food. Although the Staph. aureus organism may be killed by heat treatment, the toxin, which is quite heat stable, may remain unaffected and cause subsequent foodborne illness and the commonly exhibited emetic food poisoning symptoms. In contrast, Clostridium botulinum, the most heat resistant food-related pathogen of concern, pro duces an exotoxin, which is readily denatured by heating. Terms, such as enterotoxin and neurotoxin associated with, in this instance, Staph. aureus and the also Gram-positive C. botulinum, describe either the mode of action of the toxin, or the target tissues. Some bacterial toxins have specific cytotoxic activity, such as C. botulinum neurotoxin (BoNT), of which there are seven antigenic types labelled BoNT A to G, affecting only nerve tis sues and preventing the proper functioning of neurotransmitters. Dembek et al. (2007) reported that human botulism was caused by BoNT A, B, E and F, and that the different neurotoxins exhibit different toxicities and persistence in cells. Other bacteria, such as Bacillus cereus, have a broad, non-specific cytotoxic activity, affecting various cells and tissue types causing non-specific cellular necrosis. Bacterial protein toxins exhibit strongly antigenic properties, although in some instances antitoxins can be used to neu tralise their toxicity. In the fight against bacterial disease, toxoids can be produced from bacterial protein toxins by exposing the compounds to a combination of reagents, such as formalin and organic acids, and moderate heat. The toxoids can then be used to provide artificial immunisation against diseases, such as diphtheria. Such immunisation is desir able where infectious bacterial diseases are concerned, but is not normally practiced in relation to food-borne disease organisms of the kind associated with food poisoning.
Mycotoxins are a class of toxic compound produced by fungi. In contrast to bacterial toxins, they are of lesser concern to the dairy industry as mycotoxin producing fungi do not commonly grow on dairy products. Fungi normally associated with dairy products tend to be limited to organisms, such as Penicillium roqueforti used to produce mould ripened blue cheeses, for example, Stilton and Roquefort, and Geotrichum candidum used in the manu facture of white mould ripened soft cheeses, for example, Neufchatel, Camembert and Brie. The mycotoxins of concern to food safety are secondary metabolites, released from fungal cells during growth. They include aflatoxins (AFs), produced by Aspergillus species, such as Aspergillus flavus and Aspergillus parasiticus, Fusarium spp. mould toxins, ochratoxin pro duced by various Aspergillus spp. and Penicillium spp., patulin, produced by Penicillium expansum, amongst other species, and ergot, the cause of ergotism and produced by the fungus Claviceps purpurea. Mycotoxins are generally associated with the spoilage of com modity crops, such as cereals spoiled in the field by, for example, Fusarium spp. or Clav. purpurea, and harvested seeds and nuts kept in store, such as cereal grains, peanuts, and so on, contaminated with aflatoxins from the growth of Aspergillus spp.
From the perspective of the dairy industry, perhaps the main cause of concern with mycotoxins is the possibility of the transmission of these toxic compounds from con taminated animal feed through the cow (or other milk producing animal) into milk. The risk then exists that mycotoxin residues in milk may be carried into dairy products, affecting consumers. As stated by the International Dairy Federation (IDF, 2012), the ability of a mycotoxin or its metabolite to be excreted in milk will depend on the ability of the compound to pass the blood-milk barrier. The IDF records that the only myco toxin which has been shown to possess this ability to any significance is AF B 1 , which is excreted in milk as AF M 1 . Aflatoxin M 1 is presumed to be carcinogenic, affecting the liver, but is considerably less so than AF B 1, by a factor of 10.
Bacterial toxins
It is a well established fact that bacterial pathogens can cause food-borne diseases in humans, and the possible routes of infection with relevance to dairy products are: (a) ingestion of already produced toxin(s) (i.e. sensu stricto), and (b) ingestion of a patho genic bacterium that is capable of producing toxins in the gastrointestinal (GI) tract (in situ). The micro-organisms that have been identified to cause food-borne illness via the consumption of dairy products belong to the genera of Staphylococcus (i.e. production of staphylococcal enterotoxin -SE), Clostridium (production of BoNT) and Bacillus (emetic type). These micro-organisms including their toxin production are reviewed extensively in Chapter 3; however, readers are referred to the following selected refer ences for complete discussion of food-borne diseases including dairy products (Cary et al., 2000; Hui et al., 2001; Labbe & Garcia, 2001; De Buyser et al., 2001; de Leon et al., 2003; Jay et al., 2005; Granum, 2006; Heidinger et al., 2009; Argudín et al., 2010; Hale, 2012; Claeys et al., 2013 Claeys et al., , 2014 Hadrya et al., 2013) .
Staphylococcal enterotoxins (SEs)
According to Paulin et al. (2012) , some characteristics of SEs in milk and dairy products are summarised as follows:
• The SEs pass through the stomach into the intestinal tract where they stimulate eme sis and diarrhoea.
• Common symptoms are nausea, vomiting, retching, abdominal cramping and diarrhoea.
• Symptoms start 1-6 h after consuming food containing SEs and resolve within 1-3 d without the need for treatment.
• Food poisoning containing SEs is not usually fatal, but some fatalities can occur in very young or old people.
• Dairy-borne outbreaks in many countries are associated with consumption of dairy products made from raw milk that cause SEs intoxications.
• Pasteurisation of milk inactivates Staph. aureus, whilst cheeses made from raw milk do not have such an elimination step; thus, safety is not guaranteed.
• In general, staphylococci are inactivated by D 60°C of 6 min and the presence of lactoperoxidase in milk enhances the inactivation of Staph. aureus, decreasing its D value 15-fold; however, SEs are heat-stable at 121°C for 15 min.
• At present, 23 SE serotypes have been identified, and the potential for enterotoxin to occur in cheese can be defined as: (a) the initial concentration of Staph. aureus in milk prior to cheesemaking must be sufficient, (b) the genes in Staph. aureus must be able to encode SE production in cheese milk, (c) the environmental conditions of pH, temperature and other factors must be suitable to permit bacterial growth and enterotoxin production, and (d) subsequent treatments, such as scalding the curd and brining may inactivate Staph. aureus, but any enterotoxin which has been formed is unlikely to be destroyed in the cheese.
It is of interest to note that some strains of staphylococci are used as secondary starter cultures for the manufacture of certain cheese varieties, and according to Bockelmann (2010) , "Staphylococcus xylosus and Staphylococcus carnosus are used in certain varie ties of cheese to optimise the texture and aroma development. They are used as cheese adjuncts in starter cultures, or can be brushed or sprayed onto the cheese surface. These strains exhibit medium proteolytic and low lipolytic and aminopeptidase activities." "Staphylococcus equorum is ubiquitous in cheese brines. It became available as starter culture only recently, and it has similar technological properties as Staph. xylosus, which is used to optimise the texture and aroma development in the cheese. In combination with Debaromyces hansenii, Staph. equorum supports the growth of other smear type bacteria when the ripening of the cheese starts, and it has a mould-inhibiting effect. In addition, it can contribute to colour development when pigmented strains are used. Although the common consensus is that coagulase-negative staphylococci (CNS), such as Staph. equorum do not represent a concern with respect to food-borne disease, Irlinger et al. (2012) suggested that this may be changing and that CNS may produce enterotoxins harmful to humans."
In dairy-mediated staphylococcal food poisoning, cheese has been the most fre quently incriminated. In France, it accounted for about 90% of the staphylococcal-medi ated outbreaks with raw-milk cheese representing 96.2% of the recorded cheese-borne staphylococcal intoxications. Also, the high incidence of SE-producing Staph. aureus in cheese compared to other dairy products appears to be a general tendency, probably because this product provides an optimal medium for the growth of enterotoxigenic Staph. aureus, which thrives in media rich in protein and with a high salt content (Singh et al., 2012) , as is the case for many types of cheeses. Also, the commonly applied mesophilic temperature (25-37°C) during fermentation allows the pathogen to grow rapidly and produce enterotoxins before conditions are no longer favourable (active development of lactic acid by lactic acid bacteria (LAB) and consequent pH drop).
"Staphylococcus spp. are salt-and acid-tolerant micro-organisms, which can grow at the early stages of cheese ripening when the pH is still below 6, and they are found in all kinds of surface ripened cheeses. Like the yeasts, Staph. equorum is found in the cheese brine, sometimes at high cell counts (max. 10 5 colony forming units (cfu) mL −1
). When the cheese brine is pasteurised, frequently to reduce the yeast counts (a practice adopted by many soft cheese producers), no or very low concentrations of staphylo cocci are present. Species most frequently observed on smear cheeses are Staph. equorum (natural flora), Staph. xylosus (cultural flora), and the nonfood-grade Staphylococcus saprophyticus (natural contamination)." "Staphylococcus equorum and Staph. xylosus seem to be the typical, naturally occurring species in cheese brines and on most smear cheeses. In a different study, all 150 cocci of a smeared Gouda cheese and a Bergkaese isolated from organic farmhouse cheese producer in Northern Germany were classified as Staph. equorum by amplified ribosomal deoxyribonucleic acid (DNA) restriction analysis (ARDRA) method. This was confirmed when staphylococci, which were isolated from French smeared soft cheeses of three different producers, were identified by species and strain level. The Staph. equorum flora consisted of a variety of strains, typical of a house flora, whereas all Staph. xylosus isolates showed identical DNA restriction patterns in pulsed-field gel-electrophoresis, which matched the pattern of a commercial Staph. xylosus strain, indicating that this organism was added as a starter culture." "Staphylococcus saprophyticus is a nonfood-grade species, and it is repeatedly isolated in low numbers from smear-ripened cheeses and brine. Acid curd cheese (Harzer) seems to be an exception, where Staph. saprophyticus can be predominant in the staphylococcal surface flora, and can grow to high counts (e.g. 10 9 cfu cm −2
)" -(Source: Technology of Cheesemaking, reproduced with permission of Wiley-Blackwell).
Bacillus cereus group enterotoxins
A wide range of enterotoxins are produced by B. cereus (see Chapter 3), and some char acteristics of these toxins include: (a) the identified toxins are: emetic toxins (heat-stable at 126°C for 90 min), haemolysin BL (Bbl) (heat-labile and inactivated at 56°C for 30 min, for details refer to Chapter 3), non-haemolytic enterotoxin (Nhe) isoforms A, B and C (heat-labile and inactivated at 56°C for 30 min), and cytotoxic toxin (Cyt) isoforms K 1 and K 2 (heat-labile and inactivated at 56°C for 30 min), (b) the symptoms of food-or dairyborne illnesses include nausea, abdominal cramps, watery diarrhoea and/or vomiting, and (c) the food-poisoning symptoms are caused by intoxication with the peptide cereulide, and the diarrheal form of B. cereus food poisoning is caused by enterotoxins produced by growth of B. cereus in the small intestine after ingestion of viable cells or spores.
Clostridium botulinum nerotoxin
The symptoms of botulism are caused by the ingestion of highly soluble exotoxin pro duced by C. botulinum while growing in foods or dairy products compared to the food poisoning of Clostridium perfringens where large numbers of viable cells must be ingested (for more details, refer to Chapter 3). The toxin produced is known as BoNT, and seven serotypes have been identified, for example, BoNT A to G; only types A, B, E, F and G cause diseases in humans (Jay et al., 2005) .
The (IARC, 1993a (IARC, , 2002a (IARC, , 2002b ; see also www.afro. who.int/des). The most likely predominant genera of fungi to produce mycotoxins in dairy products are Penicillium and Aspergillus (Frazier & Westhoff, 1988; Yousef & Juneja, 2003; Jay et al., 2005) . The former organism could originate in milk due to unhygienic milk production (i.e. cheesemaking using raw milk), or the use of secondary starter cultures (e.g. Penicillium roqueforti) for the manufacture of Blue Veined cheeses (Roquefort, Stilton, Gorgonzola, Blue d'Auvergne, Cabrales, Blauschimmelkase, Tulum and Danablue) and white mould cheeses (Penicillium camemberti), such as Camembert, Brie and Gammelost. Although some penicilia spp. have been reported in old dairy books (Penicillium caseiocolum, Penicillium caseiocola, Penicillium candidum and Penicillium album), these are now considered biotypes of, or synonyms for, P. camemberti (Tamime, 2002) . However, Aspergillus spp. can contaminate animal feed (e.g. aflatoxins -AF), which can be excreted into the milks after being consumed by lactating cows. Another mould specie, Byssochlamys fulva, has been found in milk and can pro duce toxins (e.g. byssotoxin A, byssochlamic acid, patulin, fumitremorgin A and C, verruculogen, fischerin and eupenifeldin) (Tournas, 1994) , but none have been impli cated in dairy-borne products outbreaks, and they will not be reviewed in this chapter; however, more detailed infromation of incidences mycotoxins in dairy products that can be implicated in human health risk are reviewed in Chapter 2.
General aspects of mycotoxins Aflatoxin
According to Frazier & Westhoff (1988 ), IARC (2002a , 2002b , Yousef & Juneja (2003) and Jay et al. (2005) , AF B 1 and B 2 are produced by A. flavus, whilst A. parasiticus produces AF B 1 , B 2 , G 1 and G 2 . However, some aspergilla strains (Aspergillus nominus, Aspergillus bombycis, Aspergillus pseudotamari and Asper gillus ochraceoroseus) and Emericella venezuelensis are also AF-producers, but they are encountered less fre quently especially in dairy products, and will not be reviewed in this book. Aflatoxin B 1 is produced by all aflatoxin mould-producers, which is the most potent form of all. Some AF serotypes (AF L, LH 1 , Q 1 and P 1 ) are derived from AF B 1 , and some of the main AF characteristics are shown in Table (AF 1.1). The potent toxicity of the main six AF in descending order is as follows: AF B 1 (blue) > M 1 (blue/violet) > G 1 (green) > B 2 (blue) > M 2 (violet) and G 2 (green/blue) -data in parenthesis illustrate the fluorescence noted when viewed under ultraviolet (UV) light, where the colours designate the AF serotype (IARC, 2002a (IARC, , 2002b Jay et al., 2005) . Aflatoxins cross the human placenta, and exposure has been associated with growth impairment in young children. In general, AF production by moulds occurs in a growth environment of water activity (a w ) of 0.85 and at a temperature of 25-40°C.
Ochratoxin
Also, the genera of Aspergillus (e.g. A. ochraceus, A. westerdijkiae, A. niger, A. carbonarius, A. lacticoffeatus and A. sclerotioniger) and Penicillium (P. verrucosum and P. nordicum), which consist of many filamentous fungi, produce mycotoxin known as ochratoxin (OT) (el Khoury & Atoui, 2010; Sorrenti et al., 2013) . The metabolite, which has first identified, is known as OT A, and its related metabolites, such as OT B (i.e. dechloro analogue of OT A) and OT C (i.e. the isocoumaric derivative of OT A) (see Table 1 .1). The International Union of Pure and Applied Chemistry (IUPAC) names of OT A to C are as follows: The florescence colour noted viewed under UV light for OT A is greenish, whilst OT B emits blueish (Jay et al., 2005) . According to Frazier & Westhoff (1988) , although the effects of OTs to human beings are unknown or possibly slightly toxic, the significance of OTs in food is of interest for the following aspects:
• OTs are toxic to certain animals; • Some OTs are heat resistant, and are not destroyed after prolonged autoclaving; • Many OTs-producing moulds are able to grow and produce mycotoxin at tempera tures below 10°C; and • Ochratoxins have been isolated from many foods.
Citrinin
Mould organisms belonging to the following genera: Aspergillus (A. niveus, A. ochraceus, A. oryzae and A. terreus) , Monascus (M. ruber and M. purpureus) and Penicillium (P. citrinum and P. viridicatum and P. camemberti) have been reported to produce myco toxin known as citrinin (Jay et al., 2005 ; http://en.wikipedia.org/wiki/Citrinin). Citrinin is also known as antimycin and, according to the IUPAC, it is known as (3R,4S)-8-hydroxy-3,4,5-trimethyl-6-oxo-4,6-dihydro-3H-isochromene-7-carboxylic acid. It is the 2,3-dihydroform of AF G It is a nephrotoxin, and can permeate through the human skin. Although no significant health risk is expected after dermal contact in agricultural or residential environments but, nevertheless, it should be limited. 
